Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in HIV Seropositivity: HELP
Kholoud Porter
Based on 26 articles published since 2007
||||
Expertise Level
The expertise of Kholoud Porter ranks in the
  • Top 0.17%
  • ... of 23,576 published authors worldwide on HIV Seropositivity
  • ... from 2007 through 2018
  • ... based on contributions to 26 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
Expert badge
similar to this:
 
Work Locations
Details
Most likely:    University College London      
2017
  • Université Paris Descartes, Sorbonne Paris Cité, Paris, France. · Inserm UMR-S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Université Pierre et Marie Curie, Paris, France. · Inserm, CESP Centre for Research in Epidemiology and Population Health, U1018, HIV Epidemiology, Le Kremlin-Bicêtre, F-94276, France. · Univ Paris-Sud, UMRS 1018, Faculté de Médecine Paris-Sud, Le Kremlin-Bicêtre, F-94276, France. · Robert Koch Institute, HIV and other Retroviruses, Berlin, Germany. · AP-HP, Hopital Bicêtre, Epidemiology and Public Health Service, Le Kremlin Bicêtre, F-94276, France. · AP-HP, Laboratoire de Microbiologie Clinique, Hôpital Universitaire Necker-Enfants Malades, Paris, France. · Infectious Diseases, University of Milan, San Paolo Hospital, Milano, Italy and Health Sciences, University of Milan, San Paolo Hospital, Milano, Italy. · Medical University Innsbruck, Innsbruck, Austria. · Research Institute and University Hospital Puerta de Hierro, Majahonda, Madrid, Spain. · Medical Research Council Clinical Trials Unit, University College London, London, UK. · INSERM U941, Université Paris Diderot, Paris, France. · APHP, Laboratoire de Virologie, Hôpital Saint Louis, Paris, France. · Pubmed 29091208
  • Department of Infectious Disease Epidemiology, Imperial College London, London, United Kingdom. · Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom. · Laboratory of Experimental Virology, Department of Medical Microbiology, Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center of the University of Amsterdam, Amsterdam, the Netherlands. · Wellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, United Kingdom. · Stichting HIV Monitoring, Amsterdam, the Netherlands. · Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden. · Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden. · Division for HIV and other Retroviruses, Robert Koch Institute, Berlin, Germany. · School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland. · Swiss Institute of Bioinformatics, Lausanne, Switzerland. · HIV/STI reference laboratory, WHO collaborating centre, Institute of Tropical Medicine, Department of Clinical Science, Antwerpen, Belgium. · Department of Infection and Population Health, University College London, London, United Kingdom. · Department of Epidemiology, John Hopkins University, Baltimore, Maryland, United States of America. · Department of Infectious Disease Epidemiology, Robert Koch-Institute, Berlin, Germany. · Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland. · Institute of Medical Virology, University of Zurich, Zurich, Switzerland. · Department of Infectious Diseases, Helsinki University Hospital, Helsinki, Finland. · Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Baltimore, Maryland, United States of America. · Department of Health Security, National Institute for Health and Welfare, Helsinki, Finland. · INSERM CESP U1018, Université Paris Sud, Université Paris Saclay, APHP, Service de Santé Publique, Hôpital de Bicêtre, Le Kremlin-Bicêtre, France. · Virology Unit, Immunovirology Research Pole, Biomedical Sciences Department, Institute of Tropical Medicine, Antwerpen, Belgium. · Kymab Ltd, Cambridge, United Kingdom. · Division of Infectious Diseases, Department of Medicine, Imperial College London, London, United Kingdom. · Department of Global Health, Academic Medical Center, Amsterdam, the Netherlands. · Pubmed 28604782
2015
  • MRC Clinical Trials Unit at University College London, London, United Kingdom. · Western General Hospital, Edinburgh, United Kingdom. · Brighton and Sussex University NHS Trust, Brighton, United Kingdom. · Department of Infection and Population Health, University College London, London, United Kingdom. · Chelsea and Westminster Hospital, London, United Kingdom. · HIV i-Base, London, United Kingdom. · Guy's and St. Thomas NHS Trust at Kings College, London, United Kingdom. · Charing Cross Hospital, London, United Kingdom. · Imperial College NHS Trust, London, United Kingdom. · Public Health England, London, United Kingdom. · Pubmed 26225723
2014
  • Medical Research Council Clinical Trials Unit at University College London, London, United Kingdom. · Institut National de la Santé et de la Recherche Médicale U1018, Université Paris-Sud, le Kremlin-Bicêtre, France. · Amsterdam Public Health Service, Amsterdam, Netherlands. · Institut National de la Santé et de la Recherche Médicale U897, Université Bordeaux Segalen, Bordeaux, France. · Wellcome Trust Sanger Institute, Hinxton, United Kingdom ; University of Cambridge, Cambridge, United Kingdom. · Institut National de la Santé et de la Recherche Médicale U943, Paris, France ; Université Pierre et Marie Curie S943, Paris, France. · Université Paris Descartes, EA 3620, Hôpital Necker-Enfants Malades, Paris, France. · International AIDS Vaccine Initiative, San Francisco, California, United States of America. · Pubmed 24489776
2015
  • aImperial College London bKings College Hospital NHS Foundation Trust cMedical Research Council Clinical Trials Unit at University College London, London, UK dKirby Institute, University of New South Wales, Sydney, Australia eBrighton and Sussex University Hospitals, Brighton, UK fOspedale San Raffaele, Milan, Italy gProjeto Praça Onze, Hospital Escola São Francisco de Assis, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil hHospital Clinic-Institut d'investigacions Biomèdiques August Pi I Sunyer, University of Barcelona, Barcelona, Spain iLondon School of Hygiene & Tropical Medicine, London, UK. *Kholoud Porter and Sarah Fidler contributed equally to the writing of this manuscript. · Pubmed 25870986
2014
  • aImperial College London bKings College Hospital NHS Foundation Trust cMedical Research Council Clinical Trials Unit at University College London, London, UK dKirby Institute, University of New South Wales, Sydney, New South Wales, Australia eOspedale San Raffaele, Milan, Italy fProjeto Praça Onze, Hospital Escola São Francisco de Assis, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil gHospital Clinic-Institut d'investigacions Biomèdiques August Pi I Sunyer, University of Barcelona, Barcelona, Spain. · Pubmed 24300544
2013
  • Medical Research Council, University College London, London, United Kingdom ; Instituto de Salud Carlos III, Madrid, Spain. · Pubmed 24086588
  • aInstitut Pasteur, Emerging Diseases Epidemiology Unit, Paris bINSERM U1018, Centre de Recherche en Epidémiologie et Santé des Populations, Le Kremlin-Bicêtre cFaculté de Médecine Paris Sud, Université Paris Sud, Paris dDepartment of Public Health, AP-HP, Bicêtre Hospital, Le Kremlin-Bicêtre, France eMedical Research Council, Clinical Trials Unit, London, UK fCluster Infectious Diseases, Department of Research, Center for Infection and Immunity Amsterdam (CINIMA), Public Health Service, Amsterdam, The Netherlands gResearch Department of Infection and Population Health, UCL Medical School, London, UK hSan Paolo Hospital, Milan, Italy iInternational AIDS Vaccine Initiative, San Francisco, USA jRobert Koch Institut, Berlin, Germany kUlleval Hospital, Oslo, Norway lINSERM U1012, Le Kremlin-Bicêtre mDepartment of Internal Medicine, AP-HP, Bicêtre Hospital, Le Kremlin-Bicêtre nUniversité Paris-Sud, Paris, France. · Pubmed 23912979
2011
  • MRC Clinical Trials Unit, University College London, UK. · Pubmed 21921225
2010
  • HIV Epidemiology and Biostatistics Group, Research Department of Infection and Population Health, UCL Medical School, Royal Free Campus, London, UK. · Pubmed 20638118
2007
  • Royal Free Centre for HIV Medicine, Royal Free and University College Medical School, London, UK. · Pubmed 17503661
Probable:    Medical Research Council      
2017
  • Université Paris Descartes, Sorbonne Paris Cité, Paris, France. · Inserm UMR-S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Université Pierre et Marie Curie, Paris, France. · Inserm, CESP Centre for Research in Epidemiology and Population Health, U1018, HIV Epidemiology, Le Kremlin-Bicêtre, F-94276, France. · Univ Paris-Sud, UMRS 1018, Faculté de Médecine Paris-Sud, Le Kremlin-Bicêtre, F-94276, France. · Robert Koch Institute, HIV and other Retroviruses, Berlin, Germany. · AP-HP, Hopital Bicêtre, Epidemiology and Public Health Service, Le Kremlin Bicêtre, F-94276, France. · AP-HP, Laboratoire de Microbiologie Clinique, Hôpital Universitaire Necker-Enfants Malades, Paris, France. · Infectious Diseases, University of Milan, San Paolo Hospital, Milano, Italy and Health Sciences, University of Milan, San Paolo Hospital, Milano, Italy. · Medical University Innsbruck, Innsbruck, Austria. · Research Institute and University Hospital Puerta de Hierro, Majahonda, Madrid, Spain. · Medical Research Council Clinical Trials Unit, University College London, London, UK. · INSERM U941, Université Paris Diderot, Paris, France. · APHP, Laboratoire de Virologie, Hôpital Saint Louis, Paris, France. · Pubmed 29091208
2015
  • MRC Clinical Trials Unit at University College London, London, United Kingdom. · Western General Hospital, Edinburgh, United Kingdom. · Brighton and Sussex University NHS Trust, Brighton, United Kingdom. · Department of Infection and Population Health, University College London, London, United Kingdom. · Chelsea and Westminster Hospital, London, United Kingdom. · HIV i-Base, London, United Kingdom. · Guy's and St. Thomas NHS Trust at Kings College, London, United Kingdom. · Charing Cross Hospital, London, United Kingdom. · Imperial College NHS Trust, London, United Kingdom. · Public Health England, London, United Kingdom. · Pubmed 26225723
2014
  • Medical Research Council Clinical Trials Unit at University College London, London, United Kingdom. · Institut National de la Santé et de la Recherche Médicale U1018, Université Paris-Sud, le Kremlin-Bicêtre, France. · Amsterdam Public Health Service, Amsterdam, Netherlands. · Institut National de la Santé et de la Recherche Médicale U897, Université Bordeaux Segalen, Bordeaux, France. · Wellcome Trust Sanger Institute, Hinxton, United Kingdom ; University of Cambridge, Cambridge, United Kingdom. · Institut National de la Santé et de la Recherche Médicale U943, Paris, France ; Université Pierre et Marie Curie S943, Paris, France. · Université Paris Descartes, EA 3620, Hôpital Necker-Enfants Malades, Paris, France. · International AIDS Vaccine Initiative, San Francisco, California, United States of America. · Pubmed 24489776
2013
  • Medical Research Council, University College London, London, United Kingdom ; Instituto de Salud Carlos III, Madrid, Spain. · Pubmed 24086588
  • aInstitut Pasteur, Emerging Diseases Epidemiology Unit, Paris bINSERM U1018, Centre de Recherche en Epidémiologie et Santé des Populations, Le Kremlin-Bicêtre cFaculté de Médecine Paris Sud, Université Paris Sud, Paris dDepartment of Public Health, AP-HP, Bicêtre Hospital, Le Kremlin-Bicêtre, France eMedical Research Council, Clinical Trials Unit, London, UK fCluster Infectious Diseases, Department of Research, Center for Infection and Immunity Amsterdam (CINIMA), Public Health Service, Amsterdam, The Netherlands gResearch Department of Infection and Population Health, UCL Medical School, London, UK hSan Paolo Hospital, Milan, Italy iInternational AIDS Vaccine Initiative, San Francisco, USA jRobert Koch Institut, Berlin, Germany kUlleval Hospital, Oslo, Norway lINSERM U1012, Le Kremlin-Bicêtre mDepartment of Internal Medicine, AP-HP, Bicêtre Hospital, Le Kremlin-Bicêtre nUniversité Paris-Sud, Paris, France. · Pubmed 23912979
  • Clinical Trials Unit, Medical Research Council, London, UK. · Pubmed 23117980
2011
  • MRC Clinical Trials Unit, University College London, UK. · Pubmed 21921225
2010
  • MRC Clinical Trials Unit, London, UK. · Pubmed 20885283
  • Medical Research Council, Clinical Trials Unit, 222 Euston Rd, London NW1 2DA, UK. · Pubmed 20442214
2008
  • MRC Clinical Trials Unit, 222 Euston Rd, London NW1 2DA, United Kingdom. · Pubmed 18594040
  • MRC Clinical Trials Unit, London, UK. · Pubmed 18090396
  • Medical Research Council Clinical Trials Unit, London, United Kingdom. · Pubmed 17894380
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 26 total) written by Kholoud Porter about HIV Seropositivity:

  • CD4 T cell decline following HIV seroconversion in individuals with and without CXCR4-tropic virus. 2017
  • Viral genetic variation accounts for a third of variability in HIV-1 set-point viral load in Europe. 2017
  • The Impact of HCV Infection Duration on HIV Disease Progression and Response to cART amongst HIV Seroconverters in the UK. 2015
  • The effect of short-course antiretroviral therapy initiated in primary HIV-1 infection on interleukin-6 and D-dimer levels. 2015
  • An evaluation of HIV elite controller definitions within a large seroconverter cohort collaboration. 2014
  • Interleukin-6 and D-dimer levels at seroconversion as predictors of HIV-1 disease progression. 2014
  • Symptomatic illness and low CD4 cell count at HIV seroconversion as markers of severe primary HIV infection. 2013
  • Role of HIV infection duration and CD4 cell level at initiation of combination anti-retroviral therapy on risk of failure. 2013
  • Natural history of HIV-control since seroconversion. 2013
  • Effect of HCV infection on cause-specific mortality after HIV seroconversion, before and after 1997. 2013
Show List of Full Article Records
Google Searches

Learn more about Kholoud Porter using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University College London
Medical Research Council
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University College London
2017
  • Université Paris Descartes, Sorbonne Paris Cité, Paris, France. · Inserm UMR-S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Université Pierre et Marie Curie, Paris, France. · Inserm, CESP Centre for Research in Epidemiology and Population Health, U1018, HIV Epidemiology, Le Kremlin-Bicêtre, F-94276, France. · Univ Paris-Sud, UMRS 1018, Faculté de Médecine Paris-Sud, Le Kremlin-Bicêtre, F-94276, France. · Robert Koch Institute, HIV and other Retroviruses, Berlin, Germany. · AP-HP, Hopital Bicêtre, Epidemiology and Public Health Service, Le Kremlin Bicêtre, F-94276, France. · AP-HP, Laboratoire de Microbiologie Clinique, Hôpital Universitaire Necker-Enfants Malades, Paris, France. · Infectious Diseases, University of Milan, San Paolo Hospital, Milano, Italy and Health Sciences, University of Milan, San Paolo Hospital, Milano, Italy. · Medical University Innsbruck, Innsbruck, Austria. · Research Institute and University Hospital Puerta de Hierro, Majahonda, Madrid, Spain. · Medical Research Council Clinical Trials Unit, University College London, London, UK. · INSERM U941, Université Paris Diderot, Paris, France. · APHP, Laboratoire de Virologie, Hôpital Saint Louis, Paris, France. · Pubmed 29091208
  • Department of Infectious Disease Epidemiology, Imperial College London, London, United Kingdom. · Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom. · Laboratory of Experimental Virology, Department of Medical Microbiology, Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center of the University of Amsterdam, Amsterdam, the Netherlands. · Wellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, United Kingdom. · Stichting HIV Monitoring, Amsterdam, the Netherlands. · Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden. · Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden. · Division for HIV and other Retroviruses, Robert Koch Institute, Berlin, Germany. · School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland. · Swiss Institute of Bioinformatics, Lausanne, Switzerland. · HIV/STI reference laboratory, WHO collaborating centre, Institute of Tropical Medicine, Department of Clinical Science, Antwerpen, Belgium. · Department of Infection and Population Health, University College London, London, United Kingdom. · Department of Epidemiology, John Hopkins University, Baltimore, Maryland, United States of America. · Department of Infectious Disease Epidemiology, Robert Koch-Institute, Berlin, Germany. · Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland. · Institute of Medical Virology, University of Zurich, Zurich, Switzerland. · Department of Infectious Diseases, Helsinki University Hospital, Helsinki, Finland. · Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Baltimore, Maryland, United States of America. · Department of Health Security, National Institute for Health and Welfare, Helsinki, Finland. · INSERM CESP U1018, Université Paris Sud, Université Paris Saclay, APHP, Service de Santé Publique, Hôpital de Bicêtre, Le Kremlin-Bicêtre, France. · Virology Unit, Immunovirology Research Pole, Biomedical Sciences Department, Institute of Tropical Medicine, Antwerpen, Belgium. · Kymab Ltd, Cambridge, United Kingdom. · Division of Infectious Diseases, Department of Medicine, Imperial College London, London, United Kingdom. · Department of Global Health, Academic Medical Center, Amsterdam, the Netherlands. · Pubmed 28604782
2015
  • MRC Clinical Trials Unit at University College London, London, United Kingdom. · Western General Hospital, Edinburgh, United Kingdom. · Brighton and Sussex University NHS Trust, Brighton, United Kingdom. · Department of Infection and Population Health, University College London, London, United Kingdom. · Chelsea and Westminster Hospital, London, United Kingdom. · HIV i-Base, London, United Kingdom. · Guy's and St. Thomas NHS Trust at Kings College, London, United Kingdom. · Charing Cross Hospital, London, United Kingdom. · Imperial College NHS Trust, London, United Kingdom. · Public Health England, London, United Kingdom. · Pubmed 26225723
2014
  • Medical Research Council Clinical Trials Unit at University College London, London, United Kingdom. · Institut National de la Santé et de la Recherche Médicale U1018, Université Paris-Sud, le Kremlin-Bicêtre, France. · Amsterdam Public Health Service, Amsterdam, Netherlands. · Institut National de la Santé et de la Recherche Médicale U897, Université Bordeaux Segalen, Bordeaux, France. · Wellcome Trust Sanger Institute, Hinxton, United Kingdom ; University of Cambridge, Cambridge, United Kingdom. · Institut National de la Santé et de la Recherche Médicale U943, Paris, France ; Université Pierre et Marie Curie S943, Paris, France. · Université Paris Descartes, EA 3620, Hôpital Necker-Enfants Malades, Paris, France. · International AIDS Vaccine Initiative, San Francisco, California, United States of America. · Pubmed 24489776
2015
  • aImperial College London bKings College Hospital NHS Foundation Trust cMedical Research Council Clinical Trials Unit at University College London, London, UK dKirby Institute, University of New South Wales, Sydney, Australia eBrighton and Sussex University Hospitals, Brighton, UK fOspedale San Raffaele, Milan, Italy gProjeto Praça Onze, Hospital Escola São Francisco de Assis, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil hHospital Clinic-Institut d'investigacions Biomèdiques August Pi I Sunyer, University of Barcelona, Barcelona, Spain iLondon School of Hygiene & Tropical Medicine, London, UK. *Kholoud Porter and Sarah Fidler contributed equally to the writing of this manuscript. · Pubmed 25870986
2014
  • aImperial College London bKings College Hospital NHS Foundation Trust cMedical Research Council Clinical Trials Unit at University College London, London, UK dKirby Institute, University of New South Wales, Sydney, New South Wales, Australia eOspedale San Raffaele, Milan, Italy fProjeto Praça Onze, Hospital Escola São Francisco de Assis, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil gHospital Clinic-Institut d'investigacions Biomèdiques August Pi I Sunyer, University of Barcelona, Barcelona, Spain. · Pubmed 24300544
2013
  • Medical Research Council, University College London, London, United Kingdom ; Instituto de Salud Carlos III, Madrid, Spain. · Pubmed 24086588
  • aInstitut Pasteur, Emerging Diseases Epidemiology Unit, Paris bINSERM U1018, Centre de Recherche en Epidémiologie et Santé des Populations, Le Kremlin-Bicêtre cFaculté de Médecine Paris Sud, Université Paris Sud, Paris dDepartment of Public Health, AP-HP, Bicêtre Hospital, Le Kremlin-Bicêtre, France eMedical Research Council, Clinical Trials Unit, London, UK fCluster Infectious Diseases, Department of Research, Center for Infection and Immunity Amsterdam (CINIMA), Public Health Service, Amsterdam, The Netherlands gResearch Department of Infection and Population Health, UCL Medical School, London, UK hSan Paolo Hospital, Milan, Italy iInternational AIDS Vaccine Initiative, San Francisco, USA jRobert Koch Institut, Berlin, Germany kUlleval Hospital, Oslo, Norway lINSERM U1012, Le Kremlin-Bicêtre mDepartment of Internal Medicine, AP-HP, Bicêtre Hospital, Le Kremlin-Bicêtre nUniversité Paris-Sud, Paris, France. · Pubmed 23912979
2011
  • MRC Clinical Trials Unit, University College London, UK. · Pubmed 21921225
2010
  • HIV Epidemiology and Biostatistics Group, Research Department of Infection and Population Health, UCL Medical School, Royal Free Campus, London, UK. · Pubmed 20638118
2007
  • Royal Free Centre for HIV Medicine, Royal Free and University College Medical School, London, UK. · Pubmed 17503661
Medical Research Council
2017
  • Université Paris Descartes, Sorbonne Paris Cité, Paris, France. · Inserm UMR-S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Université Pierre et Marie Curie, Paris, France. · Inserm, CESP Centre for Research in Epidemiology and Population Health, U1018, HIV Epidemiology, Le Kremlin-Bicêtre, F-94276, France. · Univ Paris-Sud, UMRS 1018, Faculté de Médecine Paris-Sud, Le Kremlin-Bicêtre, F-94276, France. · Robert Koch Institute, HIV and other Retroviruses, Berlin, Germany. · AP-HP, Hopital Bicêtre, Epidemiology and Public Health Service, Le Kremlin Bicêtre, F-94276, France. · AP-HP, Laboratoire de Microbiologie Clinique, Hôpital Universitaire Necker-Enfants Malades, Paris, France. · Infectious Diseases, University of Milan, San Paolo Hospital, Milano, Italy and Health Sciences, University of Milan, San Paolo Hospital, Milano, Italy. · Medical University Innsbruck, Innsbruck, Austria. · Research Institute and University Hospital Puerta de Hierro, Majahonda, Madrid, Spain. · Medical Research Council Clinical Trials Unit, University College London, London, UK. · INSERM U941, Université Paris Diderot, Paris, France. · APHP, Laboratoire de Virologie, Hôpital Saint Louis, Paris, France. · Pubmed 29091208
2015
  • MRC Clinical Trials Unit at University College London, London, United Kingdom. · Western General Hospital, Edinburgh, United Kingdom. · Brighton and Sussex University NHS Trust, Brighton, United Kingdom. · Department of Infection and Population Health, University College London, London, United Kingdom. · Chelsea and Westminster Hospital, London, United Kingdom. · HIV i-Base, London, United Kingdom. · Guy's and St. Thomas NHS Trust at Kings College, London, United Kingdom. · Charing Cross Hospital, London, United Kingdom. · Imperial College NHS Trust, London, United Kingdom. · Public Health England, London, United Kingdom. · Pubmed 26225723
2014
  • Medical Research Council Clinical Trials Unit at University College London, London, United Kingdom. · Institut National de la Santé et de la Recherche Médicale U1018, Université Paris-Sud, le Kremlin-Bicêtre, France. · Amsterdam Public Health Service, Amsterdam, Netherlands. · Institut National de la Santé et de la Recherche Médicale U897, Université Bordeaux Segalen, Bordeaux, France. · Wellcome Trust Sanger Institute, Hinxton, United Kingdom ; University of Cambridge, Cambridge, United Kingdom. · Institut National de la Santé et de la Recherche Médicale U943, Paris, France ; Université Pierre et Marie Curie S943, Paris, France. · Université Paris Descartes, EA 3620, Hôpital Necker-Enfants Malades, Paris, France. · International AIDS Vaccine Initiative, San Francisco, California, United States of America. · Pubmed 24489776
2013
  • Medical Research Council, University College London, London, United Kingdom ; Instituto de Salud Carlos III, Madrid, Spain. · Pubmed 24086588
  • aInstitut Pasteur, Emerging Diseases Epidemiology Unit, Paris bINSERM U1018, Centre de Recherche en Epidémiologie et Santé des Populations, Le Kremlin-Bicêtre cFaculté de Médecine Paris Sud, Université Paris Sud, Paris dDepartment of Public Health, AP-HP, Bicêtre Hospital, Le Kremlin-Bicêtre, France eMedical Research Council, Clinical Trials Unit, London, UK fCluster Infectious Diseases, Department of Research, Center for Infection and Immunity Amsterdam (CINIMA), Public Health Service, Amsterdam, The Netherlands gResearch Department of Infection and Population Health, UCL Medical School, London, UK hSan Paolo Hospital, Milan, Italy iInternational AIDS Vaccine Initiative, San Francisco, USA jRobert Koch Institut, Berlin, Germany kUlleval Hospital, Oslo, Norway lINSERM U1012, Le Kremlin-Bicêtre mDepartment of Internal Medicine, AP-HP, Bicêtre Hospital, Le Kremlin-Bicêtre nUniversité Paris-Sud, Paris, France. · Pubmed 23912979
  • Clinical Trials Unit, Medical Research Council, London, UK. · Pubmed 23117980
2011
  • MRC Clinical Trials Unit, University College London, UK. · Pubmed 21921225
2010
  • MRC Clinical Trials Unit, London, UK. · Pubmed 20885283
  • Medical Research Council, Clinical Trials Unit, 222 Euston Rd, London NW1 2DA, UK. · Pubmed 20442214
2008
  • MRC Clinical Trials Unit, 222 Euston Rd, London NW1 2DA, United Kingdom. · Pubmed 18594040
  • MRC Clinical Trials Unit, London, UK. · Pubmed 18090396
  • Medical Research Council Clinical Trials Unit, London, United Kingdom. · Pubmed 17894380
13 Other Locations Show
Yearly article counts 020227323041
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.